Disposition of 5800 shares by Domingo Angelita Rebamontan of Pro Dex subject to Rule 16b-3
| PDEX Stock | USD 46.75 0.84 1.83% |
Slightly above 56% of all Pro Dex's investors are looking to take a long position. The analysis of overall sentiment of trading Pro Dex stock suggests that some investors are interested at this time. Pro Dex's investing sentiment can be driven by a variety of factors including economic data, Pro Dex's earnings reports, geopolitical events, and overall market trends.
Pro |
Filed transaction by Pro Dex Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at finance.yahoo.com
 |
Pro Dex Fundamental Analysis
We analyze Pro Dex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Dex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Dex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Pro Dex is currently under evaluation in target price category among its peers.
Pro Dex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pro Dex stock to make a market-neutral strategy. Peer analysis of Pro Dex could also be used in its relative valuation, which is a method of valuing Pro Dex by comparing valuation metrics with similar companies.
Peers
Pro Dex Related Equities
| INFU | InfuSystems Holdings | 5.62 | ||||
| MLSS | Milestone Scientific | 3.23 | ||||
| UTMD | Utah Medical | 0.94 | ||||
| CLPBY | Coloplast | 0.64 | ||||
| NEPH | Nephros | 0.68 | ||||
| SAUHY | Straumann Holding | 0.72 | ||||
| LMAT | LeMaitre Vascular | 0.87 | ||||
| KRMD | Repro Med | 1.03 |
Additional Tools for Pro Stock Analysis
When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.